PharmaShots | Incisive News in 3 Shots

Subscribe Now

Small Lymphocytic Lymphoma

TG Therapeutics Reports the US FDA's Acceptance of BLA for Ublituximab + Ukoniq (umbralisib) to Treat Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

TG Therapeutics Reports the US FDA's Acceptance of BLA for Ublituximab + Ukoniq (umbralisib) to Treat Chronic Lymphocytic Leukemia...

May 26, 2021

BeiGene Reports Results of Brukinsa (zanubrutinib) in P-III Head-to-Head APSEN Trial for R/R Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

BeiGene Reports Results of Brukinsa (zanubrutinib) in P-III Head-to-Head APSEN Trial for R/R Chronic Lymphocytic Leukemia or Small...

April 29, 2021

AbbVie's Imbruvica (ibrutinib) + Gazyva (obinutuzumab) Receives FDA's Approval- First CT Free Treatment for 1L+ CLL/SLL

AbbVie's Imbruvica (ibrutinib) + Gazyva (obinutuzumab) Receives FDA's Approval- First CT Free Treatment for 1L+ CLL/SLL

January 28, 2019

Verastem Oncology's Copiktra (duvelisib) Receives FDA Approval for r/r 2L+ Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Verastem Oncology's Copiktra (duvelisib) Receives FDA Approval for r/r 2L+ Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma...

September 24, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us